Bellon Steven F.
SEC insider (Form 3/4/5 filer). CIK 0001831749. Chief Scientific Officer at Foghorn Therapeutics Inc. (FHTX). 3 reported Form 4/5 transactions since Sep 2024; latest on Jan 30, 2026. Located in WATERTOWN, MA.
Companies Bellon Steven F. has filed insider reports for
- Foghorn Therapeutics Inc. (FHTX): Officer, Chief Scientific Officer
Bellon Steven F.
CIK: 0001831749
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (33.3%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
FHTX
Foghorn Therapeutics Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 30, 2026FHTX
Foghorn Therapeutics Inc.
AwardDirectStock Option (right to buy)
300K shares at avg. $5.71- - Jan 22, 2025FHTX
Foghorn Therapeutics Inc.
AwardDirectStock Option (right to buy)
140K shares at avg. $4.37- - Sep 9, 2024FHTX
Foghorn Therapeutics Inc.
SaleDirect20K shares at avg. $9.50$190K
1-3 of 3 transactions